397 related articles for article (PubMed ID: 19758158)
1. Relevance of anti-C1q autoantibodies to lupus nephritis.
Tsirogianni A; Pipi E; Soufleros K
Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
[TBL] [Abstract][Full Text] [Related]
2. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of autoantibodies against C1q in children with glomerulonephritis.
Kozyro I; Perahud I; Sadallah S; Sukalo A; Titov L; Schifferli J; Trendelenburg M
Pediatrics; 2006 May; 117(5):1663-8. PubMed ID: 16651321
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
[TBL] [Abstract][Full Text] [Related]
7. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
10. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
11. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
Flierman R; Daha MR
Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
[TBL] [Abstract][Full Text] [Related]
13. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].
Trendelenburg M; Schifferli JA
Praxis (Bern 1994); 1998 Dec; 87(51-52):1811-3. PubMed ID: 10025155
[TBL] [Abstract][Full Text] [Related]
14. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
15. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q autoantibodies in lupus nephritis.
Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
Yin Y; Wu X; Shan G; Zhang X
Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943
[TBL] [Abstract][Full Text] [Related]
18. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
Deliyska B; Tsacheva I; Radanova M; Stoianova V; Tchorbadjieva M; Dobreva N
Med Pregl; 2007; 60 Suppl 2():25-7. PubMed ID: 18928152
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
20. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
Moura CG; Mangueira CL; Cruz LA; Cruz CM
Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]